OptiNose, Inc. (NASDAQ:OPTN)

About the company

OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.

Sector

Health Services

Industry

Medical and Nursing Services

Employees

224

$37.00M

Total Revenue

224

Employees

$277.35M

Market Capitalization

-2.52

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$31M

Operating Margin (in %)

Total operating margin

$-94M

Net Margin (in %)

Total net margin

$-109M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
DaVita, Inc. DVA 11671.20 11487.00 5.07 12.95 7.85
Chemed Corp. CHE 7945.12 1992.00 10.85 33.41 11.60
Guardant Health, Inc. GH 7770.15 245.00 10.52 -100.66 -31.53
Amedisys, Inc. AMED 6736.62 1980.00 9.73 53.02 6.43
LHC Group, Inc. LHCG 5518.93 2091.00 3.93 56.16 4.73
1Life Healthcare, Inc. ONEM 4827.06 292.00 10.38 -60.81 -27.31
NeoGenomics, Inc. NEO 3591.28 419.00 7.37 847.00 0.82
Natera, Inc. NTRA 3509.84 330.00 14.61 -28.28 -38.27
SmileDirectClub, Inc. SDC 3118.50 769.00 9.88 -25.31 -16.02
Invitae Corp. NVTA 3045.12 241.00 12.15 -9.97 -125.90
The Ensign Group, Inc. ENSG 2376.08 2155.00 3.37 19.20 5.76
Acadia Healthcare Co., Inc. ACHC 2250.16 3130.00 0.92 19.98 3.61
MEDNAX, Inc. MD 1449.18 3508.00 1.00 -1.14 -36.30
Addus HomeCare Corp. ADUS 1289.96 598.00 3.05 62.68 3.33
U.S. Physical Therapy, Inc. USPH 1051.18 478.00 4.31 35.78 6.03
RadNet, Inc. RDNT 791.50 1164.00 6.46 395.75 0.18
Castle Biosciences, Inc. CSTL 665.04 61.00 7.72 652.00 9.75
The Pennant Group, Inc. PNTG 640.64 352.00 8.38 152.53 1.19
Option Care Health, Inc. OPCH 627.36 2539.00 2.65 -6.41 -3.63
Hanger, Inc. HNGR 612.18 1095.00 -38.36 32.88 1.71
Tivity Health, Inc. TVTY 540.00 1255.00 70.31 -1.09 -38.98
Catasys, Inc. CATS 440.13 41.00 -16.08 -14.15 -74.67
Fulgent Genetics, Inc. FLGT 324.20 35.00 4.32 -1621.00 -1.31
OptiNose, Inc. OPTN 277.35 37.00 8.38 -2.52 -295.66
American Renal Associates Holdings, Inc. ARA 205.12 824.00 -2.54 -11.45 -2.19
Aptinyx, Inc. APTX 179.64 4.00 1.86 -3.22 -810.48
Exagen, Inc. XGN 165.75 41.00 3.19 -5.18 -76.21
CRH Medical Corp. CRHM 163.52 117.00 2.15 112.00 1.52
Pro-Dex, Inc. PDEX 71.72 31.00 3.98 16.30 14.50
Guardion Health Sciences, Inc. GHSI 36.63 1.00 2.69 -1.60 -824.43
Cardiff Oncology, Inc. CRDF 30.17 0.00 12.31 -1.97 -883.77
OncoSec Medical, Inc. ONCS 25.61 None 2.10 -0.68 None
Biocept, Inc. BIOC 25.08 6.00 3.88 -0.92 -463.58
Capital Senior Living Corp. CSU 21.60 439.00 -0.69 -0.31 -16.00
American Shared Hospital Services AMS 12.66 20.00 0.46 52.75 1.28
IMAC Holdings, Inc. IMAC 10.98 16.00 1.26 -1.63 -42.30
TrovaGene, Inc. TROV 8.04 0.00 2.03 -0.48 -883.77

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Stock Alert: OptiNose Up 17%

3d ago, source: Nasdaq

(OPTN) jumped over 17% on Tuesday morning after pharmaceutical company announced an anti-COVID-19 product candidate. OPTN is ...

Is OptiNose the Next Big Coronavirus Stock?

3d ago, source: 24/7 Wall St on MSN.com

Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat and allergy specialists. In terms of the specifics, the company ...

OptiNose Inc (NASDAQ:OPTN) Receives Average Rating of “Buy” from Analysts

9d ago, source: theenterpriseleader.com

Shares of OptiNose Inc (NASDAQ:OPTN) have earned a consensus rating of “Buy” from the eight analysts that are currently ...

Bank of New York Mellon Corp Grows Stake in OptiNose Inc (NASDAQ:OPTN)

13d ago, source: theenterpriseleader.com

Bank of New York Mellon Corp raised its stake in OptiNose Inc (NASDAQ:OPTN) by 1.7% during the first quarter, according to ...

Optinose to develop COVID-19 treatment

3d ago, source: Seeking Alpha

Optinose (OPTN +25.2%) initiates development of a new product candidate, OPN-019, which will combine the Company’s proprietary nasal Exhalation Delivery System (EDS) technology with an ...

Optinose launches development of COVID-19 prophylactic treatment

3d ago, source: Seeking Alpha

Optinose (OPTN +25.2%) initiates development of a new product candidate, OPN-019, which will combine the Company’s proprietary nasal Exhalation Delivery System (EDS) technology with an ...

Optinose to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

11d ago, source: Stockhouse

YARDLEY, Pa., June 22, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.